Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The journey of a drug from laboratory concept to patient treatment is a complex chemical endeavor, heavily reliant on the precise synthesis of key intermediates. For Elagolix, a significant GnRH antagonist, understanding its core intermediates is crucial for pharmaceutical manufacturers and researchers. This article delves into the chemical significance of 5-(2-Fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione, commonly known as Elagolix Intermediate and identified by CAS number 1150560-59-0.
Elagolix functions by antagonizing the gonadotropin-releasing hormone (GnRH) receptor, thereby reducing the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This hormonal modulation is key in treating conditions like endometriosis and uterine fibroids. The synthesis of such a complex molecule requires highly specific and pure precursor compounds. The Elagolix Intermediate (CAS 1150560-59-0) plays a pivotal role as a foundational structural element in this multi-step synthesis. Its unique combination of fluorinated aromatic rings and a substituted pyrimidinedione core provides the necessary scaffolding for building the final Elagolix molecule.
The presence of fluorine atoms in the molecule, specifically the trifluoromethyl group and the fluoro substituents on the phenyl rings, are critical. Fluorine incorporation often enhances metabolic stability, lipophilicity, and binding affinity of pharmaceutical compounds. In the case of Elagolix Intermediate, these features are strategically placed to influence the conformation and electronic properties of the molecule, which are ultimately imparted to the final API. Manufacturers seeking to produce Elagolix must ensure a consistent and high-quality supply of this intermediate, often from specialized chemical suppliers in China.
The synthesis pathway typically involves coupling reactions where the Elagolix Intermediate is meticulously modified and elaborated. The purity of this intermediate directly impacts the yield and purity of the subsequent reaction steps, and crucially, the final Elagolix API. Impurities in the intermediate can lead to the formation of undesirable byproducts, complicating purification processes and potentially compromising patient safety. Therefore, when purchasing this compound, specifying a high purity level and verifying the supplier's quality control processes is paramount. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing pharmaceutical-grade intermediates, including CAS 1150560-59-0, ensuring that our clients receive the highest quality materials for their critical drug development and manufacturing needs. Inquire with us for pricing and availability to support your synthesis endeavors.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
